You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Selective Estrogen Receptor Degrader (SERD)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Resistance in ER+ Breast Cancer Patients:Translational Project

Recruiting
  • Breast Cancer
    • Aviano, Pordenone, Italy
    • +1 more
    Nov 8, 2023

    Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

    Not yet recruiting
    • Breast Cancer, Early Breast Cancer
    • (no location specified)
    Jul 11, 2023

    Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Tumor Trial in Worldwide (G1T48, Palbociclib)

    Completed
    • Carcinoma, Ductal, Breast
    • +6 more
    • Beverly Hills, California
    • +14 more
    Dec 14, 2022

    Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

    Not yet recruiting
    • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
    • (no location specified)
    Sep 26, 2023

    Breast Cancer Trial in Shanghai (SCR-6852, Palbociclib)

    Recruiting
    • Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    May 18, 2022

    Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

    Not yet recruiting
    • Advanced Breast Cancer
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Sep 12, 2022

    Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

    Not yet recruiting
    • Breast Cancer
    • Breast Cancer, Early-Onset
    • (no location specified)
    Jan 18, 2023

    Healthy Subjects Trial (Camizestrant, Itraconazole)

    Completed
    • Healthy Subjects
    • Harrow, United Kingdom
      Research Site
    Jan 5, 2023

    Metastatic Breast Cancer Trial in Belgium, Netherlands (RAD1901)

    Completed
    • Metastatic Breast Cancer
    • Bruxelles, Belgium
    • +4 more
    Aug 16, 2022

    HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

    Active, not recruiting
    Has Results
    • HIV Infections
    • Birmingham, Alabama
    • +13 more
    Jan 13, 2022

    Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

    Active, not recruiting
    Has Results
    • Androgen Receptor Positive
    • +5 more
    • Corona, California
    • +6 more
    Jun 8, 2022

    Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Aug 12, 2022

    Breast Cancer, Breast Cancer Metastatic, Hormone Receptor Positive Tumor Trial (INX-315)

    Not yet recruiting
    • Breast Cancer
    • +8 more
    • (no location specified)
    Feb 9, 2023

    Breast Cancer Trial in Sarasota, Nashville (AC699)

    Recruiting
    • Breast Cancer
    • Sarasota, Florida
    • +1 more
    Jan 3, 2023

    Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Boston, Massachusetts
    • +7 more
    Aug 14, 2023

    Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

    Recruiting
    • Metastatic Breast Cancer
    • Anchorage, Alaska
    • +58 more
    Jan 6, 2023

    Clomiphene Citrate asInhibitor of Ovulation inOocyte

    Not yet recruiting
    • Infertility, Female
    • Infertility
    • Baton Rouge, Louisiana
      Womans Hospital
    May 17, 2023

    Breast Cancer. Real Clinical Practice in Russia

    Recruiting
    • Breast Cancer
    • Neoadjuvant Endocrine Therapy
    • Tamoxifen 20mg
    • +4 more
    • Moscow, Russian Federation
      Blokhin's Russian Cancer Research Center
    Apr 5, 2023

    Breast Cancer Trial in Denver, Sarasota, Nashville (AC682)

    Recruiting
    • Breast Cancer
    • Denver, Colorado
    • +4 more
    Dec 12, 2022

    Breast Cancer Trial in Poland, United States (ZN-c5, Abemaciclib)

    Recruiting
    • Breast Cancer
    • Gilbert, Arizona
    • +6 more
    Feb 14, 2022

    Schizophrenia, Schizoaffective Disorder Trial in Melbourne (Raloxifene HCl, Placebo)

    Completed
    • Schizophrenia
    • Schizoaffective Disorder
    • Raloxifene hydrochloride
    • Placebo
    • Melbourne, Victoria, Australia
      Monash Alfred Psychiatry Research Centre
    Jan 6, 2020

    Breast Cancer Recurrent Trial in Worldwide (Palbociclib 125mg, Standard endocrine therapy)

    Recruiting
    • Breast Cancer Recurrent
    • Palbociclib 125mg
    • Standard endocrine therapy
    • Graz, Austria
    • +52 more
    Nov 15, 2022

    Breast Cancer Trial in Beijing, Hangzhou, Tianjin (AC682)

    Not yet recruiting
    • Breast Cancer
    • Beijing, China
    • +2 more
    Aug 3, 2022

    Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Melbourne (Raloxifene Hydrochloride, Placebo)

    Unknown status
    • Schizophrenia
    • +2 more
    • Raloxifene Hydrochloride
    • Placebo
    • Melbourne, Victoria, Australia
      Alfred Hospital
    Jan 6, 2020